Erratum: Insurance and Cost-Related Access Barriers to Specialty Oral Anticancer Medications for Blood Cancers in a Nationwide Sample of Medicare and Commercially Insured Patients.

IF 44.7 1区医学 Q1 ONCOLOGY

Journal of Clinical Oncology Pub Date : 2026-10-14 DOI:10.1200/JCO-26-02527

Jalpa A Doshi, Pengxiang Li, Zhi Geng, Matthew J Klebanoff, Amy R Pettit, Katrina A Armstrong, Scott F Huntington, John K Lin

引用次数: 0

查看原文本刊更多论文

勘误：在全国范围内的医疗保险和商业保险患者样本中，血癌专业口服抗癌药物的保险和费用相关准入障碍。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Oncology 医学-肿瘤学

CiteScore

41.20

自引率

2.20%

发文量

8215

审稿时长

2 months

期刊介绍： The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.